Clinical studies with angiogenesis inhibitors: biological rationale and challenges for their evaluation.
Gasparini
G
G
Presta
M
M
D043925:Angiogenesis Inducing Agents / Q000502:physiology; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D009389:Neovascularization, Pathologic / Q000188:drug therapy*; D018919:Neovascularization, Physiologic / Q000502:physiology; D011379:Prognosis
D043925:Angiogenesis Inducing Agents; D000970:Antineoplastic Agents